Vesiculovirus Neutralization by Natural IgM and Complement

Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors

(2013) B-Y Hwang et al.   GENE THERAPY

PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice

(2013) M. Z. Tesfay et al.   JOURNAL OF VIROLOGY

LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus

(2013) D. Finkelshtein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

(2012) S Naik et al.   CANCER GENE THERAPY

Curative one-shot systemic virotherapy in murine myeloma

(2012) S Naik et al.   LEUKEMIA

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling

(2012) Megan Moerdyk-Schauwecker et al.   VIROLOGY

Genetic and antigenic relationships of vesicular stomatitis viruses from South America

(2011) Steven J. Pauszek et al.   ARCHIVES OF VIROLOGY

Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus

(2010) Jan Brun et al.   MOLECULAR THERAPY

Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers

(2010) Chunsheng Liu et al.   MOLECULAR THERAPY

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

(2009) Vassiliki Saloura et al.   HUMAN GENE THERAPY

Combined VSV Oncolytic Virus and Chemotherapy for Squamous Cell Carcinoma

(2009) Chih-Kwang Sung et al.   LARYNGOSCOPE

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

(2009) J P Laubach et al.   LEUKEMIA

Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy

(2009) Candice Willmon et al.   MOLECULAR THERAPY

Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells

(2009) Grant D Trobridge et al.   MOLECULAR THERAPY

Impaired interferon signaling is a common immune defect in human cancer

(2009) R. J. Critchley-Thorne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The pathogenesis of the bone disease of multiple myeloma

(2008) Claire M. Edwards et al.   BONE

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors

(2008) Y. Wu et al.   CLINICAL CANCER RESEARCH

Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy

(2008) A T Power et al.   GENE THERAPY

Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth

(2008) A Munguia et al.   GENE THERAPY

Early Steps of the Virus Replication Cycle Are Inhibited in Prostate Cancer Cells Resistant to Oncolytic Vesicular Stomatitis Virus

(2008) B. L. Carey et al.   JOURNAL OF VIROLOGY